| Zhang, Bingzhong |
| Not yet recruiting | 3 | 420 | RoW | Anlotinib hydrochloride capsule + TQB2450 injection, Chemotherapy drug | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Endometrial Cancer | 12/27 | 06/29 | | |
TQB2450-II-08, NCT04574284: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer |
|
|
| Recruiting | 2 | 196 | RoW | TQB2450, Anlotinib | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Endometrial Cancer | 12/21 | 04/22 | | |
NCT05112991: Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer |
|
|
| Recruiting | 2 | 108 | RoW | Envafolimab+Lenvatinib, Envafolimab | 3D Medicines (Sichuan) Co., Ltd. | Advanced Endometrial Cancer | 03/25 | 10/25 | | |
TQB2450-II-14, NCT05481645: Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus. |
|
|
| Recruiting | 2 | 79 | RoW | TQB2450 injection, Anlotinib Hydrochloride Capsule, Carboplatin Injection, Paclitaxel Injection, Doxorubicin Hydrochloride Injection, Gemcitabine Hydrochloride Injection, Docetaxel injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Endometrial Cancer, Sarcoma of Uterus | 06/24 | 12/24 | | |
NCT05866354: To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid Malignancies |
|
|
| Completed | 1 | 19 | RoW | Tisotumab Vedotin | Zai Lab (Shanghai) Co., Ltd. | Solid Malignancies | 11/23 | 11/23 | | |
NCT06083779: Early Detection of Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics |
|
|
| Recruiting | N/A | 216 | RoW | low-depth whole-genome sequencing technology | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Nanjing Geneseeq Technology Inc. | Endometrial Cancer | 01/24 | 04/24 | | |
NCT05693974: Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study) |
|
|
| Active, not recruiting | N/A | 130 | RoW | | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Nanjing Geneseeq Technology Inc. | Ovarian Cancer | 01/23 | 04/23 | | |
NCT05693987: Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study) |
|
|
| Recruiting | N/A | 248 | RoW | | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Nanjing Geneseeq Technology Inc. | Ovarian Cancer | 02/23 | 04/23 | | |
| Qunxian, Rao |
NCT05185713: The Mechanism of Vaginal Flora and Its Metabolites in the Pathogenesis of Cervical Cancer |
|
|
| Not yet recruiting | N/A | 300 | RoW | This project is a clinical observational study. No additional medication or surgical interventions are performed on the subjects. | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Cervical Cancer | 01/23 | 01/23 | | |
NCT05175326: Study on the Consistency Evaluation of Organoids Used in the Clinical Treatment of Ovarian Cancer With Anti-tumor Drugs |
|
|
| Recruiting | N/A | 64 | RoW | | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Ovarian Cancer, Organoid | 06/22 | 11/22 | | |
NCT05693987: Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study) |
|
|
| Recruiting | N/A | 248 | RoW | | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Nanjing Geneseeq Technology Inc. | Ovarian Cancer | 02/23 | 04/23 | | |
| Lu, huaiwu |
| Recruiting | 2 | 40 | RoW | Camrelizumab, Cisplatin, Nab paclitaxel, biopsy | Tongji Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Women Hospital, School of Medicine, Zhejiang University, Third Military Medical University, Beijing Friendship Hospital, Sichuan Cancer Hospital and Research Institute, Tianjin Medical University, West China Second University Hospital, Xiangya Hospital of Central South University, Qilu Hospital of Shandong University, Gansu Cancer Hospital, Zhejiang Cancer Hospital, Shengjing Hospital, Anhui Provincial Cancer Hospital | Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Fertility Preservation | 12/25 | 12/30 | | |
NCT05251883: A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics |
|
|
| Recruiting | N/A | 200 | RoW | | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Ovarian Cancer | 12/23 | 12/26 | | |
| Recruiting | N/A | 168 | RoW | Blood collection | Fudan University, Shanghai Weihe Medical Laboratory Co., Ltd. | Ovarian Cancer | 12/25 | 12/26 | | |
NCT06533709: Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data |
|
|
| Recruiting | N/A | 146 | RoW | Radio-score | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Ovarian Cancer, Image, Predation | 05/26 | 05/26 | | |
NCT05806125: Clinical Value of the Fertility-preserving Surgery in Cervical Cancer |
|
|
| Recruiting | N/A | 100 | RoW | | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Cervical Cancer | 12/24 | 12/24 | | |
NCT05904977: Preliminary Study on the Metastatic Rate and Clinical Significance of the Anterior Leaf of Vesicouterine Ligament in Early Stage Cervical Cancer |
|
|
| Recruiting | N/A | 460 | RoW | Type B resection or type C resection of the anterior leaf of vesicouterine ligament during the radical hysterectomy (type C) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Cervical Cancer | 12/24 | 12/24 | | |
NCT05863377: Efficacy of Chemotherapy Alone in Patients With Poor-differentiated Early-stage Cervical Cancer |
|
|
| Recruiting | N/A | 450 | RoW | | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Cervical Cancer | 12/24 | 12/24 | | |
